ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids
Authors
Keywords
-
Journal
Journal of Addiction Medicine
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-07-29
DOI
10.1097/adm.0000000000001202
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl
- (2023) Gail D’Onofrio et al. JAMA Network Open
- High-Dose Buprenorphine Initiation in the Emergency Department Among Patients Using Fentanyl and Other Opioids
- (2023) Hannah Snyder et al. JAMA Network Open
- Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
- (2023) Ashish P. Thakrar et al. Addiction Science & Clinical Practice
- A Plea From People Who Use Drugs to Clinicians
- (2022) Kimberly L. Sue et al. Journal of Addiction Medicine
- Management of Xylazine Withdrawal in a Hospitalized Patient
- (2022) Rachel Ehrman-Dupre et al. Journal of Addiction Medicine
- Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients
- (2022) Laurence M. Moss et al. PLoS One
- Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis
- (2022) Joseph Friedman et al. DRUG AND ALCOHOL DEPENDENCE
- Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review
- (2022) Lauren A. Spreen et al. PHARMACOTHERAPY
- Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials
- (2022) Andrew W. Bergen et al. International Journal of Environmental Research and Public Health
- A Neuropharmacological Model to Explain Buprenorphine Induction Challenges
- (2022) Mark K. Greenwald et al. ANNALS OF EMERGENCY MEDICINE
- Buprenorphine Initiation in the Era of High-Potency Synthetic Opioids: A Call for Community-Based Participatory Research to Help Learning Health Systems Provide Precision Medicine for Opioid Use Disorder
- (2022) David A. Fiellin Journal of Addiction Medicine
- Adapting methadone inductions to the fentanyl era
- (2022) Megan Buresh et al. JOURNAL OF SUBSTANCE ABUSE TREATMENT
- Factors Associated with Long-Term Retention in Buprenorphine-Based Addiction Treatment Programs: a Systematic Review
- (2021) Amy J. Kennedy et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone
- (2021) Benjamin Rolland et al. DRUG AND ALCOHOL DEPENDENCE
- Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction
- (2021) Caroline B. Pantazis et al. Science Advances
- Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease
- (2021) Ryan R. Cook et al. DRUG AND ALCOHOL DEPENDENCE
- High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
- (2021) Andrew A. Herring et al. JAMA Network Open
- Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: A retrospective case series
- (2021) Alyssa M. Peckham et al. JOURNAL OF SUBSTANCE ABUSE TREATMENT
- Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl
- (2021) John J. Mariani et al. AMERICAN JOURNAL ON ADDICTIONS
- Low Dose Initiation of Buprenorphine
- (2021) Shawn M. Cohen et al. Journal of Addiction Medicine
- Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use
- (2021) Christian Hailozian et al. Journal of Addiction Medicine
- Medication treatment for opioid use disorder in expectant mothers (MOMs): Design considerations for a pragmatic randomized trial comparing extended-release and daily buprenorphine formulations
- (2020) Theresa Winhusen et al. Contemporary Clinical Trials
- Subcutaneous Buprenorphine Extended-Release Use Among Pregnant and Postpartum Women
- (2020) Erin M. Cleary et al. OBSTETRICS AND GYNECOLOGY
- Short communication: Systematic review on effectiveness of micro-induction approaches to buprenorphine initiation
- (2020) Jessica Moe et al. ADDICTIVE BEHAVIORS
- Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
- (2018) Adam Bisaga et al. DRUG AND ALCOHOL DEPENDENCE
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder
- (2018) Michelle R. Lofwall et al. JAMA Internal Medicine
- Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States
- (2018) Wei-Hsuan Lo-Ciganic et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals
- (2018) Andrew S. Huhn et al. ANESTHESIOLOGY
- Single high-dose buprenorphine for opioid craving during withdrawal
- (2018) Jamshid Ahmadi et al. Trials
- Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder
- (2017) Sharon L. Walsh et al. JAMA Psychiatry
- Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder
- (2016) Celine M. Laffont et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder
- (2016) Azmi F. Nasser et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- (2013) Yih-Ing Hser et al. ADDICTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started